Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Ruoyao Wang"'
Autor:
Ruoyao Wang, Long Cheng, Lingyun He, Chier Du, Haiyang Wang, Bohao Peng, Xiaoqing Yu, Weiwei Liu, Wenpei Luo, Haitao Ran, Lu Yang
Publikováno v:
Journal of Nanobiotechnology, Vol 22, Iss 1, Pp 1-22 (2024)
Abstract Background Breast cancer ranks first among malignant tumors, of which triple-negative breast cancer (TNBC) is characterized by its highly invasive behavior and the worst prognosis. Timely diagnosis and precise treatment of TNBC are substanti
Externí odkaz:
https://doaj.org/article/888a4e4468fe470691b5d498ccba8874
Autor:
Weixuan Lei, Mengqi Shao, Yan Hu, Jieming Cao, Wei Han, Ruoyao Wang, Quanming Fei, Jian Zou, Junqi Yi, Zheyu Cheng, Wenliang Liu
Publikováno v:
BMC Pediatrics, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Background Pectus excavatum, the most common chest wall deformity, is frequently treated with Nuss procedure. Here we will describe non-invasive procedure and analyze the variables associated vacuum bell therapy for patients with pectus exca
Externí odkaz:
https://doaj.org/article/febc1a74331a486c9bab60bd2d6078bb
Autor:
Chier Du, Xun Guo, Xiaoling Qiu, Weixi Jiang, Xiaoting Wang, Hongjin An, Jingxue Wang, Yuanli Luo, Qianying Du, Ruoyao Wang, Chen Cheng, Yuan Guo, Hua Teng, Haitao Ran, Zhigang Wang, Pan Li, Zhiyi Zhou, Jianli Ren
Publikováno v:
Advanced Science, Vol 11, Iss 15, Pp n/a-n/a (2024)
Abstract Overproduction of reactive oxygen species (ROS), metal ion accumulation, and tricarboxylic acid cycle collapse are crucial factors in mitochondria‐mediated cell death. However, the highly adaptive nature and damage‐repair capabilities of
Externí odkaz:
https://doaj.org/article/26627474b79a430f9d05ee77d51935bb
Publikováno v:
Frontiers in Bioscience-Landmark, Vol 28, Iss 9, p 207 (2023)
Tumor-associated macrophages (TAMs) are the most abundant infiltrating immune cells in the tumor microenvironment (TME) and play an important role in tumor progression. Clinically, the increase of TAMs infiltration is linked to poor prognosis of pati
Externí odkaz:
https://doaj.org/article/e532826094374bf780071846eedf0f7c
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Background: Alectinib, a highly selective inhibitor of ALK, is currently used in the first-line setting of untreated advanced ALK-positive NSCLC and in the second-line setting of crizotinib-resistant ALK-positive NSCLC. Despite promising efficacy and
Externí odkaz:
https://doaj.org/article/05e3b3bb3ebf461c8fb582963bb01621
Autor:
Yan Hu, Siying Ren, Lulu Yang, Zhongyi Tong, Ruoyao Wang, Wei Han, Chao Zeng, Jina Li, Peng Xiao, Li Wang, Fenglei Yu, Wenliang Liu
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Background: Evidence of osimertinib as neoadjuvant therapy for resectable non-small cell lung cancer (NSCLC) are currently lacking. This case series study aimed to assess the safety and feasibility of neoadjuvant osimertinib therapy followed by surge
Externí odkaz:
https://doaj.org/article/1217976f0fa445ae8060dca1fee98c08
Autor:
Meaghan Emery-Wetherell, Ruoyao Wang
Publikováno v:
Assessment & Evaluation in Higher Education. :1-16
Publikováno v:
Journal of Chromatography B. 1225:123762
Autor:
Ruoyao Wang
Publikováno v:
Computer-Aided Design and Applications. 19:21-31
Autor:
Ruoyao Wang, Dongdong Xia, Xudong Jiang, Chaowei Zhao, Shengxi Zhou, Haisheng Fang, Jing Wang, Zheng Tang, Chengyi Xiao, Weiwei Li
Publikováno v:
ACS applied materialsinterfaces. 14(42)
In this work, we have introduced single/double-sided N-annulated perylene bisimide (PBI) with deep energy levels into double-cable polymers with poly[1-(5-(4,8-bis(4-chloro-5-(2-ethylhexyl)thiophen-2-yl)-6-methylbenzo[1,2